These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33638931)

  • 1. Effects of simvastatin on tissue factor pathway of blood coagulation in STATCOPE (Simvastatin in the prevention of COPD exacerbations) trial.
    Rao AK; Del Carpio-Cano F; Janapati S; Zhao H; Voelker H; Lu X; Criner G;
    J Thromb Haemost; 2021 Jul; 19(7):1709-1717. PubMed ID: 33638931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
    Criner GJ; Connett JE; Aaron SD; Albert RK; Bailey WC; Casaburi R; Cooper JA; Curtis JL; Dransfield MT; Han MK; Make B; Marchetti N; Martinez FJ; Niewoehner DE; Scanlon PD; Sciurba FC; Scharf SM; Sin DD; Voelker H; Washko GR; Woodruff PG; Lazarus SC; ;
    N Engl J Med; 2014 Jun; 370(23):2201-10. PubMed ID: 24836125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease.
    Vaidyula VR; Criner GJ; Grabianowski C; Rao AK
    Thromb Res; 2009 Jul; 124(3):259-61. PubMed ID: 19162305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Simvastatin and extrinsic coagulation pathway in peritoneally dialyzed patients].
    Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Myśliwiec M
    Pol Arch Med Wewn; 2002 Jun; 107(6):519-24. PubMed ID: 12371384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
    van 't Veer C; Mann KG
    J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
    Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
    Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
    Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
    Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor pathway.
    McVey JH
    Baillieres Clin Haematol; 1994 Sep; 7(3):469-84. PubMed ID: 7841596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men.
    Hansen JB; Grimsgaard S; Huseby N; Sandset PM; Bønaa KH
    Thromb Res; 2001 Apr; 102(1):3-13. PubMed ID: 11323009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease.
    Kaczmarek P; Sładek K; Skucha W; Rzeszutko M; Iwaniec T; Dziedzina S; Szczeklik A
    Pol Arch Med Wewn; 2010; 120(1-2):11-7. PubMed ID: 20150839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor.
    Jesty J; Lorenz A; Rodriguez J; Wun TC
    Blood; 1996 Mar; 87(6):2301-7. PubMed ID: 8630391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study.
    Brodin E; Børvik T; Sandset PM; Bønaa KH; Nordøy A; Hansen JB
    Thromb Haemost; 2004 Jul; 92(1):178-84. PubMed ID: 15213859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
    Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
    Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
    Boden G; Vaidyula VR; Homko C; Cheung P; Rao AK
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4352-8. PubMed ID: 17785358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative systems pharmacology model of blood coagulation network describes in vivo biomarker changes in non-bleeding subjects.
    Lee D; Nayak S; Martin SW; Heatherington AC; Vicini P; Hua F
    J Thromb Haemost; 2016 Dec; 14(12):2430-2445. PubMed ID: 27666750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.
    El-Ghoroury EA; El-Din HG; Abdel-Kader M; Ragab S
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):7-13. PubMed ID: 18180609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial.
    John ME; Cockcroft JR; McKeever TM; Coward WR; Shale DJ; Johnson SR; Thornton JG; Harrison TW; Knox AJ; Bolton CE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():211-21. PubMed ID: 25673981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients.
    Hölschermann H; Hilgendorff A; Kemkes-Matthes B; Schönburg M; Bauer EP; Tillmanns H; Haberbosch W
    Transplantation; 2000 May; 69(9):1830-6. PubMed ID: 10830219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
    Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.